Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Improvement in Red Blood Cell Physiology in Children with Sickle Cell Anemia Receiving Voxelotor

Satheesh Chonat, MD, Earl Fields, Hannah Baratz, Amanda Watt, Mira Pochron, PhD, Sandy Dixon, Margaret Tonda, PharmD, Joshua Lehrer-Graiwer, MD MPhil, FACC, Clark Brown, MD PhD, David R. Archer, PhD

Blood (2019) 134 (Supplement_1): 2281.

https://doi.org/10.1182/blood-2019-129351

Published: 2019

Journal Articles

PP-14, a Novel Structurally-Enhanced Antisickling Allosteric Hemoglobin Effector, Increases Oxygen Affinity and Disrupts Hemoglobin S Polymer Formation

Martin K. Safo, PhD, Piyusha P Pagare, PhD, Mohini Ghatge, PhD, Carla Casu, PhD, Valentina Ghiaccio, PhD, Nancy Anabaraonye, Xiaomeng Xu, MS, Stefano Rivella, PhD, Patrick C. Hines, MD PhD, Ke Liu, PhD, Yan Zhang, PhD, Jürgen Venitz, MD PhD, Osheiza Abdulmalik, DVM

Blood (2019) 134 (Supplement_1): 73.

https://doi.org/10.1182/blood-2019-128646

Published: 2019

Journal Articles

Complete Hematologic and Cytogenetic Remission of Acute Myeloid Leukemia in an Elderly Patient Treated with Decitabine and Venetoclax: A Case Report

Hanrry Jerry Paredes, MD MT(ASCP), M. Francisco Gonzalez, MD

Blood (2019) 134 (Supplement_1): 5189.

https://doi.org/10.1182/blood-2019-132019

Published: 2019

Journal Articles

Atypical Chronic Myeloid Leukemia

Chandralekha Ashangari, MD, Praveen K. Tumula, MD

Blood (2018) 132 (Supplement 1): 5455.

https://doi.org/10.1182/blood-2018-99-110189

Published: 2018

Journal Articles

The Significance of Leukocytosis in Malignancies: A Novel Paradigm Between Leukocytosis, G-CSF, Myeloid-Derived Suppressor Cells and Prognosis

Montreh Tavakkoli, MD MA, Cy Wilkins, MD, Jodi V Mones, MD, Michael J. Mauro, MD

Blood (2018) 132 (Supplement 1): 4944.

https://doi.org/10.1182/blood-2018-99-117484

Published: 2018

Journal Articles

Integrated Microfluidic Automated Particle Tracking Enables High-Throughput Cell Deformability Cytometry for Red Cell Disorders

Christina Caruso, MD, Puneeth Guruprasad, Robert G Mannino, PhD, Hanqing Zhang, PhD, Cassandra D Josephson, MD, John D Roback, MD PhD, Wilbur A Lam, MD PhD

Blood (2018) 132 (Supplement 1): 1033.

https://doi.org/10.1182/blood-2018-99-118830

Published: 2018

Journal Articles

Atypical Chronic Myeloid Leukemia Challenge in Russian Hematology Practice

Vasily Shuvaev, MD, Karina Krutikova, MD, Svetlana Menshakova, MD, Natalya Kalinova, MD, Irina Martynkevich, MD PhD, Lyubov Polushkina, MD, Elena Belyakova, MD, Yury Krivolapov, MD PhD, Sergei Voloshin, MD PhD

Blood (2018) 132 (Supplement 1): 5483.

https://doi.org/10.1182/blood-2018-99-114885

Published: 2018

Journal Articles

Hairy Cell Leukemia Variant

Chandralekha Ashangari, MD, Divya Cheruku, MD, Praveen K. Tumula, MD

Blood (2018) 132 (Supplement 1): 5562.

https://doi.org/10.1182/blood-2018-99-110192

Published: 2018

Journal Articles

Essential Thrombocythemia Versus Pre-Fibrotic/Early Primary Myelofibrosis: Discrimination By Laboratory and Clinical Data

Martin Schalling, Andreas Gleiss, Bettina Gisslinger, Albert Wölfler, Veronika Buxhofer-Ausch, Georg Jeryczynski, MD, Maria-Theresa Krauth, MD, Ingrid Simonitsch-Klupp, MD, Christine Beham-Schmid, Jurgen Thiele, Heinz Gisslinger

Blood (2017) 130 (Supplement 1): 4201.

https://doi.org/10.1182/blood.V130.Suppl_1.4201.4201

Published: 2017

Journal Articles

JAK1 Somatic Mutation in Myeloproliferative Neoplasm

Suzanne O Arulogun, MBBS, Hock Choong Lai, MBBS, Debra Taylor, BS, Paula Ambrosoli, Graham Magor, Ian Michael Irving, MBBS, FRACP, FRCPA, Tee Beng Keng, MD, Andrew C Perkins, PhD

Blood (2017) 130 (Supplement 1): 5269.

https://doi.org/10.1182/blood.V130.Suppl_1.5269.5269

Published: 2017

Journal Articles

Aberrant Clonal Hematopoiesis of the Erythroid and Myeloid Lineages in a Lentivirally Barcoded Rhesus Macaque

Diego A Espinoza, BA, Chuanfeng Wu, MD, Xing Fan, MD, Di Yang, MD, Idalia Montano Yabe, MS, Selami Demirci, PhD, So Gun Hong, PhD, Aylin Bonifacino, MS, Allen Krouse, Mark Metzger, Rong Lu, PhD, Katherine R Calvo, MD PhD, John F Tisdale, MD, Xiaolin Wu, PhD, Suk See De Ravin, MD PhD, Harry L Malech, MD, Robert E Donahue, VMD, Cynthia E Dunbar, MD

Blood (2017) 130 (Supplement 1): 606.

https://doi.org/10.1182/blood.V130.Suppl_1.606.606

Published: 2017

Journal Articles

Cellular Hydration and Oxidation As Phenotype Modifiers in Sickle Cell Anemia

Mary A Risinger, PhD, Neha Dagaonkar, Georgios E Christakopoulos, MD, Jie Liu, PhD, Katie Giger Seu, PhD, Diamantis G Konstantinidis, BSc, PhD, Charles T Quinn, MD, Satheesh Chonat, MD, Clinton H Joiner, MD PhD, Kejian Zhang, MD, Theodosia A Kalfa, MD PhD

Blood (2016) 128 (22): 2446.

https://doi.org/10.1182/blood.V128.22.2446.2446

Published: 2016

Journal Articles

Vzhe-039, a Novel Structurally-Enhanced Allosteric Hemoglobin Effector Inhibits Sickling of SS Erythrocytes In Vitro , and Exhibits Improved Pharmacologic Properties In Vivo

Martin K. Safo, PhD, Guoyan Xu, PhD, Mohini Ghatge, PhD, Qiukan Chen, Carla Casu, PhD, David Tanya, PhD, Yan Zhang, PhD, Jurgen Venitz, MD PhD, Osheiza Abdulmalik, DVM, MS

Blood (2016) 128 (22): 3645.

https://doi.org/10.1182/blood.V128.22.3645.3645

Published: 2016

Journal Articles

Multiple Brain Hemorrhages on Presentation in a Patient with Accelerated Phase Chronic Myeloid Leukemia and Subsequent CNS Blast Crisis Despite Systemic Complete Molecular Response: Possible Role of CNS Bleed in Leukemia Proliferation

Aleem Aamer, MBBS, FRCP, FRCPath, Fatmah Al Wusibai, MBBS, Khalid AlSaleh, MBBS, FRCPC, MRCP, Fatma Alqahtani, MBBS, KSU fellowship, Zafar Iqbal, PhD, Naeem A. Chaudhri, MD FACP, Abdul Kareem M Al-Momen, MD FRCPC

Blood (2015) 126 (23): 5153.

https://doi.org/10.1182/blood.V126.23.5153.5153

Published: 2015

Journal Articles

Calreticulin Mutation Status Predicts Improved Disease Outcome in Prefibrotic Primary Myelofibrosis but Not in WHO-Defined Essential Thrombocythemia

Heinz Gisslinger, MD, Juergen Thiele, MD PhD, Bettina Gisslinger, MSc, Tiina Berg, B.Sc., Martin Schalling, M.Sc., Ashot S Harutyunyan, MD, Jelena D. Milosevic, M.Sc., Klaudia Bagienski, M.Sc., Nicole C.C. Them, M.Sc., Veronika Buxhofer-Ausch, Guenther Nirnberger, Leonhard Muellauer, MD, Robert Kralovics, PhD

Blood (2014) 124 (21): 3167.

https://doi.org/10.1182/blood.V124.21.3167.3167

Published: 2014

Journal Articles

Comparison of Acute Panmyelosis with Myelofibrosis and Acute Megakaryoblastic Leukemia: A Mayo Clinic Study

Naseema Gangat, MD, Mrinal M. Patnaik, MBBS, Ben Zhang, MD

Blood (2014) 124 (21): 959.

https://doi.org/10.1182/blood.V124.21.959.959

Published: 2014

Journal Articles

Site-Directed Pegylation of BDD FVIII (BAY 94-9027) Does Not Alter the Ability of the Molecule to Generate Thrombin, Activate Factor X or Become Inactivated By Activated Protein C

Subramanian Yegneswaran, PhD, Xiaoqiao Jiang, BS, Pooja Yesantharao, Ji-Yun Kim, PhD, Lilley Leong, PhD MS, Derek S Sim, PhD, Chandra Patel, PhD, Katalin Zsofia Kauser, PhD MD DSc

Blood (2014) 124 (21): 1492.

https://doi.org/10.1182/blood.V124.21.1492.1492

Published: 2014

Journal Articles

Expression of JAK2-V617F Kinase in Myeloid Progenitors and Proerythroblasts Induces Differential Patterns of Hypersensitivity in Activation of Key Signaling Nodes upon Incubation with Low-Dose, Physiologic EPO Concentrations

Christian Mueller, MD, Nibedita Gupta, PhD, Felix C Saalfeld, cand.MD, Rolf Findeisen, D.Eng, Nadine Rudolph, PhD, Steffen Klamt, D.Eng, Sandra Heise, graduate engineer, Fred Schaper, D.Sc, Thomas Fischer, MD

Blood (2014) 124 (21): 4573.

https://doi.org/10.1182/blood.V124.21.4573.4573

Published: 2014

Journal Articles

Neutropenia during Hematopoietic Stem Cell Mobilization with G-CSF

Lezhong Yuan, MD, Hui Liu, Qiang Wang, Jing Sun, MD, Qifa Liu, MD, Hao Huang, MD, Yanyan Ye, Qianli Jiang, PhDMD

Blood (2014) 124 (21): 5835.

https://doi.org/10.1182/blood.V124.21.5835.5835

Published: 2014

Journal Articles

A Case Of Refractory Autoimmune Hemolytic Anemia In a Patient With Digeorge Syndrome Treated Successfully With Plasma Exchange

Moussab Damlaj, BSc MD, Chantal Séguin, MD

Blood (2013) 122 (21): 4829.

https://doi.org/10.1182/blood.V122.21.4829.4829

Published: 2013

NARROW

Improvement in Red Blood Cell Physiology in Children with Sickle Cell Anemia Receiving Voxelotor

PP-14, a Novel Structurally-Enhanced Antisickling Allosteric Hemoglobin Effector, Increases Oxygen Affinity and Disrupts Hemoglobin S Polymer Formation

Complete Hematologic and Cytogenetic Remission of Acute Myeloid Leukemia in an Elderly Patient Treated with Decitabine and Venetoclax: A Case Report

Atypical Chronic Myeloid Leukemia

The Significance of Leukocytosis in Malignancies: A Novel Paradigm Between Leukocytosis, G-CSF, Myeloid-Derived Suppressor Cells and Prognosis

Integrated Microfluidic Automated Particle Tracking Enables High-Throughput Cell Deformability Cytometry for Red Cell Disorders

Atypical Chronic Myeloid Leukemia Challenge in Russian Hematology Practice

Hairy Cell Leukemia Variant

Essential Thrombocythemia Versus Pre-Fibrotic/Early Primary Myelofibrosis: Discrimination By Laboratory and Clinical Data

JAK1 Somatic Mutation in Myeloproliferative Neoplasm

Aberrant Clonal Hematopoiesis of the Erythroid and Myeloid Lineages in a Lentivirally Barcoded Rhesus Macaque

Cellular Hydration and Oxidation As Phenotype Modifiers in Sickle Cell Anemia

Vzhe-039, a Novel Structurally-Enhanced Allosteric Hemoglobin Effector Inhibits Sickling of SS Erythrocytes In Vitro , and Exhibits Improved Pharmacologic Properties In Vivo

Multiple Brain Hemorrhages on Presentation in a Patient with Accelerated Phase Chronic Myeloid Leukemia and Subsequent CNS Blast Crisis Despite Systemic Complete Molecular Response: Possible Role of CNS Bleed in Leukemia Proliferation

Calreticulin Mutation Status Predicts Improved Disease Outcome in Prefibrotic Primary Myelofibrosis but Not in WHO-Defined Essential Thrombocythemia

Comparison of Acute Panmyelosis with Myelofibrosis and Acute Megakaryoblastic Leukemia: A Mayo Clinic Study

Site-Directed Pegylation of BDD FVIII (BAY 94-9027) Does Not Alter the Ability of the Molecule to Generate Thrombin, Activate Factor X or Become Inactivated By Activated Protein C

Expression of JAK2-V617F Kinase in Myeloid Progenitors and Proerythroblasts Induces Differential Patterns of Hypersensitivity in Activation of Key Signaling Nodes upon Incubation with Low-Dose, Physiologic EPO Concentrations

Neutropenia during Hematopoietic Stem Cell Mobilization with G-CSF

A Case Of Refractory Autoimmune Hemolytic Anemia In a Patient With Digeorge Syndrome Treated Successfully With Plasma Exchange

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only